Search results
Showing 31 to 45 of 74 results for cystic fibrosis
techniques in maintaining lung function in infants and children with cystic fibrosis? Any explanatory notes(if applicable) Why this is...
assessment and monitoring of changes in pulmonary status in people with cystic fibrosis? Any explanatory notes(if applicable) Why this...
for people with cystic fibrosis? Any explanatory notes(if applicable) Why this is important- People with cystic fibrosis...
functioning to use as a test for thresholds of concern in people with cystic fibrosis? Any explanatory notes(if applicable) Why this is...
Liver disease:- Should all children with meconium ileus receive ursodeoxycholic acid from diagnosis?
of mortality in people with cystic fibrosis, and around 10 to 30% of people with cystic fibrosis will develop...
Monitoring for cystic-fibrosis-related diabetes:- What is the most effective strategy to detect diabetes in people with cystic...
NICE has developed a medtech innovation briefing (MIB) on OxyMask for delivering oxygen therapy .
NICE has developed a medtech innovation briefing (MIB) on The Vest for delivering high-frequency chest wall oscillation in people with complex neurological needs .
This quality standard covers diagnosing and managing cystic fibrosis in infants, children, young people and adults. It describes high-quality care in priority areas for improvement.
View quality statements for QS168Show all sections
This guideline covers diagnosing and managing age-related macular degeneration (AMD) in adults. It aims to improve the speed at which people are diagnosed and treated to prevent loss of sight.
This guideline covers diagnosing and managing cystic fibrosis. It specifies how to monitor the condition and manage the symptoms to improve quality of life. There are also detailed recommendations on treating the most common infections in people with cystic fibrosis.
Faltering growth: recognition and management of faltering growth in children (NG75)
This guideline covers recognition, assessment and monitoring of faltering growth in infants and children. It includes a definition of growth thresholds for concern and identifying the risk factors for, and possible causes of, faltering growth. It also covers interventions, when to refer, service design, and information and support.
NICE has developed a medtech innovation briefing (MIB) on Smart One for measuring lung function .
Osteoporosis: assessing the risk of fragility fracture (CG146)
This guideline covers assessing the risk of fragility fracture in people aged 18 and over with osteoporosis. It aims to provide guidance on the selection and use of risk assessment tools in the care of adults at risk of fragility fractures in all NHS settings.
NICE has developed a medtech innovation briefing (MIB) on the ThermoCool SmartTouch catheter for percutaneous radiofrequency ablation in atrial fibrillation